معرفی
Dr. Jose Polo is a Professor in the Department of Anatomy and Developmental Biology at Monash University. He holds dual affiliations with the Australian Regenerative Medicine Institute and collaborates with institutions like Harvard University, Cornell University, and CSIRO. His research focuses on epigenetic mechanisms governing cellular identity and pluripotency, particularly through reprogramming somatic cells into induced pluripotent stem (iPS) cells.
Education:
- PhD in Molecular Biology at Albert Einstein College of Medicine (USA)
- Postdoctoral research at Harvard University under Konrad Hochedlinger
Research Interests: The lab explores transcriptional and epigenetic dynamics during cell reprogramming, including chromatin remodeling, transcription factor networks, and pluripotency maintenance. Key applications include disease modeling and regenerative therapies.
Recent Research Trends: Recent work emphasizes mechanistic insights into iPS cell generation efficiency, chromatin accessibility, and in vivo cell plasticity. Collaborative projects aim to translate findings into treatments for kidney disease and neurological disorders.
Awards:
- National Health and Medical Research Council (NHMRC) Career Development Fellowship (2012)
- Monash University Dean's Award for Early Career Research Excellence (2014)
- International recognition as Future Leader in Science & Technology (Kyoto, 2014)
Grants & Projects:
- Lead Investigator for ARC Training Centre for Cell & Tissue Engineering Technologies ($ millions funding)
- Co-leads projects on anti-fibrotic cell therapies and podocyte reprogramming
- Recipient of multiple competitive fellowships and industry partnerships
Lab & Collaborations: The Reprogramming & Epigenetics Lab collaborates globally on stem cell innovation. Active partnerships include the University of Michigan, Cornell University, and TissueGUARD GmbH for translational research.
